News - Page 246 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Champignon Brands Provides Update on Continuous Disclosure Review

Champignon Brands Provides Update on Continuous Disclosure Review

Post published:October 29, 2020
Post category:Press Release

Read more about the article Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

Entheon Go-Public Amalgamation Agreement Receives Conditional Approval from CSE

Post published:October 28, 2020
Post category:Press Release

Read more about the article Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain

Post published:October 28, 2020
Post category:Press Release

Read more about the article MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing

Post published:October 27, 2020
Post category:Press Release

Read more about the article ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic

ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic

Post published:October 27, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

Post published:October 27, 2020
Post category:Press Release

Read more about the article MAPS Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD

MAPS Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD

Post published:October 27, 2020
Post category:Press Release

Read more about the article NeonMind Manufactures 4 Superfood Mushroom Coffees

NeonMind Manufactures 4 Superfood Mushroom Coffees

Post published:October 27, 2020
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Post published:October 26, 2020
Post category:Press Release

Read more about the article COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO

Post published:October 26, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.